CIK: 0001634557
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | REYN | Reynolds Consumer Products Inc. | Stock-Other | 41.94% | — | +127.21% | |
| 2 | ALKS | Alkermes plc | Stock-Healthcare | 17.64% | — | +8.96% | |
| 3 | ABBV | Abbvie INC | Stock-Healthcare | 16.58% | — | — | |
| 4 | PRTA | Prothena Corporation plc | Stock-Other | 16.24% | — | +12.21% | |
| 5 | NWBO | Northwest Biotherapeutics | Stock-Other | 7.38% | — | +22.37% | |
| 6 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 0.23% | -71.30% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | REYN | Reynolds Consumer Products Inc. | +0.6% | +127.21% | Add |
| 2 | NWBO | Northwest Biotherapeutics | -5.4% | +22.37% | Add |
| 3 | ALKS | Alkermes plc | -5.9% | +8.96% | Add |
| 4 | PRTA | Prothena Corporation plc | -6.1% | +12.21% | Add |
| 5 | ABBV | Abbvie INC | — | NEW | New buy |
| 6 | TBPH | Theravance Biopharma, Inc. | — | NEW | New buy |